Effect of transforming growth factor-β1 on proliferation and death of rat prostatic cells

Paula Martikainen, Natasha Kyprianou, John Tod Isaacs

Research output: Contribution to journalArticle

Abstract

The ability of transforming growth factor B1 (TGFβ1) to inhibit proliferation and activate death of rat ventral prostatic glandular cells was tested both in vivo and in vitro. In vivo administration of 50 ng TGFβ1/day directly to the regressed ventral prostate of previously castrated male rats had no effect on the proliferative regrowth of the prostatic glandular cells induced by exogeneous androgen replacement. In addition, androgen-stimulated ventral prostatic cell proliferation in vitro in organ culture was not affected by exposure to 0.1-20 ng/ml TGFβ1. In contrast in vivo administration of 50 ng TGFβ1/day directly to the ventral prostate of intact noncastrated male rats resulted in the death of about 25% of the prostatic glandular cells within 7 days of treatment. Such TGFβ1 treatment did not lower serum testosterone, nor did it affect the size or DNA content of the seminal vesicles, demonstrating the local nature of the response. Likewise, in androgen-maintained ventral prostate organ cultures in vitro, there was a dose-response relationship between glandular cell death and TGFβ1 concentration in the medium. These results demonstrate that TGFβ1 can induce the death of androgen-dependent prostatic glandular cells even when physiological levels of androgen are present. Previous studies have demonstrated that both the receptor and the mRNA for TGFβ1 increase rapidly in the ventral prostate after castration. Taken with the present data, these results suggest that TGFβ1 may be a physiological intermediate in the programmed cell death of rat prostatic glandular cells activated after androgen ablation.

Original languageEnglish (US)
Pages (from-to)2963-2968
Number of pages6
JournalEndocrinology
Volume127
Issue number6
StatePublished - Dec 1990

Fingerprint

Transforming Growth Factors
Androgens
Prostate
Organ Culture Techniques
Cell Death
Seminal Vesicles
Castration
Testosterone
Cell Proliferation
Messenger RNA
DNA
Serum

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Effect of transforming growth factor-β1 on proliferation and death of rat prostatic cells. / Martikainen, Paula; Kyprianou, Natasha; Isaacs, John Tod.

In: Endocrinology, Vol. 127, No. 6, 12.1990, p. 2963-2968.

Research output: Contribution to journalArticle

Martikainen, Paula ; Kyprianou, Natasha ; Isaacs, John Tod. / Effect of transforming growth factor-β1 on proliferation and death of rat prostatic cells. In: Endocrinology. 1990 ; Vol. 127, No. 6. pp. 2963-2968.
@article{d4da3bf3315649d28f459833c76e93d4,
title = "Effect of transforming growth factor-β1 on proliferation and death of rat prostatic cells",
abstract = "The ability of transforming growth factor B1 (TGFβ1) to inhibit proliferation and activate death of rat ventral prostatic glandular cells was tested both in vivo and in vitro. In vivo administration of 50 ng TGFβ1/day directly to the regressed ventral prostate of previously castrated male rats had no effect on the proliferative regrowth of the prostatic glandular cells induced by exogeneous androgen replacement. In addition, androgen-stimulated ventral prostatic cell proliferation in vitro in organ culture was not affected by exposure to 0.1-20 ng/ml TGFβ1. In contrast in vivo administration of 50 ng TGFβ1/day directly to the ventral prostate of intact noncastrated male rats resulted in the death of about 25{\%} of the prostatic glandular cells within 7 days of treatment. Such TGFβ1 treatment did not lower serum testosterone, nor did it affect the size or DNA content of the seminal vesicles, demonstrating the local nature of the response. Likewise, in androgen-maintained ventral prostate organ cultures in vitro, there was a dose-response relationship between glandular cell death and TGFβ1 concentration in the medium. These results demonstrate that TGFβ1 can induce the death of androgen-dependent prostatic glandular cells even when physiological levels of androgen are present. Previous studies have demonstrated that both the receptor and the mRNA for TGFβ1 increase rapidly in the ventral prostate after castration. Taken with the present data, these results suggest that TGFβ1 may be a physiological intermediate in the programmed cell death of rat prostatic glandular cells activated after androgen ablation.",
author = "Paula Martikainen and Natasha Kyprianou and Isaacs, {John Tod}",
year = "1990",
month = "12",
language = "English (US)",
volume = "127",
pages = "2963--2968",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "6",

}

TY - JOUR

T1 - Effect of transforming growth factor-β1 on proliferation and death of rat prostatic cells

AU - Martikainen, Paula

AU - Kyprianou, Natasha

AU - Isaacs, John Tod

PY - 1990/12

Y1 - 1990/12

N2 - The ability of transforming growth factor B1 (TGFβ1) to inhibit proliferation and activate death of rat ventral prostatic glandular cells was tested both in vivo and in vitro. In vivo administration of 50 ng TGFβ1/day directly to the regressed ventral prostate of previously castrated male rats had no effect on the proliferative regrowth of the prostatic glandular cells induced by exogeneous androgen replacement. In addition, androgen-stimulated ventral prostatic cell proliferation in vitro in organ culture was not affected by exposure to 0.1-20 ng/ml TGFβ1. In contrast in vivo administration of 50 ng TGFβ1/day directly to the ventral prostate of intact noncastrated male rats resulted in the death of about 25% of the prostatic glandular cells within 7 days of treatment. Such TGFβ1 treatment did not lower serum testosterone, nor did it affect the size or DNA content of the seminal vesicles, demonstrating the local nature of the response. Likewise, in androgen-maintained ventral prostate organ cultures in vitro, there was a dose-response relationship between glandular cell death and TGFβ1 concentration in the medium. These results demonstrate that TGFβ1 can induce the death of androgen-dependent prostatic glandular cells even when physiological levels of androgen are present. Previous studies have demonstrated that both the receptor and the mRNA for TGFβ1 increase rapidly in the ventral prostate after castration. Taken with the present data, these results suggest that TGFβ1 may be a physiological intermediate in the programmed cell death of rat prostatic glandular cells activated after androgen ablation.

AB - The ability of transforming growth factor B1 (TGFβ1) to inhibit proliferation and activate death of rat ventral prostatic glandular cells was tested both in vivo and in vitro. In vivo administration of 50 ng TGFβ1/day directly to the regressed ventral prostate of previously castrated male rats had no effect on the proliferative regrowth of the prostatic glandular cells induced by exogeneous androgen replacement. In addition, androgen-stimulated ventral prostatic cell proliferation in vitro in organ culture was not affected by exposure to 0.1-20 ng/ml TGFβ1. In contrast in vivo administration of 50 ng TGFβ1/day directly to the ventral prostate of intact noncastrated male rats resulted in the death of about 25% of the prostatic glandular cells within 7 days of treatment. Such TGFβ1 treatment did not lower serum testosterone, nor did it affect the size or DNA content of the seminal vesicles, demonstrating the local nature of the response. Likewise, in androgen-maintained ventral prostate organ cultures in vitro, there was a dose-response relationship between glandular cell death and TGFβ1 concentration in the medium. These results demonstrate that TGFβ1 can induce the death of androgen-dependent prostatic glandular cells even when physiological levels of androgen are present. Previous studies have demonstrated that both the receptor and the mRNA for TGFβ1 increase rapidly in the ventral prostate after castration. Taken with the present data, these results suggest that TGFβ1 may be a physiological intermediate in the programmed cell death of rat prostatic glandular cells activated after androgen ablation.

UR - http://www.scopus.com/inward/record.url?scp=0025650608&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025650608&partnerID=8YFLogxK

M3 - Article

C2 - 2249636

AN - SCOPUS:0025650608

VL - 127

SP - 2963

EP - 2968

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 6

ER -